CATALENT PHARMA SOLUTIONS, INC. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/eb0dc65a-4948-4aba-8832-e27c646b34cf/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2013 | $1.8B | 2012-07-01 – 2013-06-30 | evidence 0001416083-13-000014 |
| FY 2012 | $1.7B | 2011-07-01 – 2012-06-30 | evidence 0001193125-12-378353 |
| FY 2011 | $1.5B | 2010-07-01 – 2011-06-30 | evidence 0001193125-12-378353 |
| FY 2010 | $1.5B | 2009-07-01 – 2010-06-30 | evidence 0001193125-12-378353 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CATALENT PHARMA SOLUTIONS, INC. — all facts · Net Income · Operating Income